Nikko Asset Management Americas, Inc. Iovance Biotherapeutics, Inc. Transaction History

Nikko Asset Management Americas, Inc.

$8.64 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $312,975 - $529,022	-58,391 Reduced 2.29%	2,490,600 $17.5 Million
Q1 2023 May 03, 2023	SELL	$5.53 - $8.22 $213,607 - $317,513	-38,627 Reduced 1.49%	2,548,991 $15.6 Million
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $628,287 - $1.12 Million	-111,795 Reduced 4.14%	2,587,618 $16.5 Million
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $955,182 - $1.31 Million	-100,229 Reduced 3.58%	2,699,413 $25.2 Million
Q2 2022 Aug 04, 2022	BUY	$6.38 - $18.33 $2.69 Million - $7.72 Million	421,306 Added 17.71%	2,799,642 $29.7 Million
Q1 2022 May 06, 2022	SELL	$12.38 - $19.1 $32 Million - $49.4 Million	-2,586,760 Reduced 52.1%	2,378,336 $39.2 Million
Q4 2021 Feb 08, 2022	SELL	$16.55 - $27.63 $23.4 Million - $39.1 Million	-1,415,707 Reduced 22.19%	4,965,096 $82.6 Million
Q3 2021 Nov 09, 2021	SELL	$20.35 - $26.63 $27.4 Million - $35.8 Million	-1,343,985 Reduced 17.4%	6,380,803 $145 Million
Q2 2021 Aug 09, 2021	BUY	$16.33 - $33.07 $38.8 Million - $78.7 Million	2,378,927 Added 44.5%	7,724,788 $199 Million
Q1 2021 May 03, 2021	BUY	$28.67 - $52.59 $26.4 Million - $48.5 Million	921,951 Added 20.84%	5,345,861 $169 Million
Q4 2020 Feb 11, 2021	BUY	$28.04 - $50.26 $25.4 Million - $45.4 Million	904,165 Added 25.69%	4,423,910 $205 Million
Q3 2020 Nov 02, 2020	BUY	$27.75 - $36.3 $21.2 Million - $27.8 Million	765,177 Added 27.78%	3,519,745 $116 Million
Q2 2020 Aug 07, 2020	BUY	$27.21 - $41.0 $44.5 Million - $67 Million	1,634,046 Added 145.83%	2,754,568 $75.4 Million
Q1 2020 Apr 30, 2020	SELL	$19.54 - $38.85 $4.02 Million - $8 Million	-205,987 Reduced 15.53%	1,120,522 $33.5 Million
Q4 2019 Feb 06, 2020	SELL	$17.95 - $29.41 $534,784 - $876,212	-29,793 Reduced 2.2%	1,326,509 $36.7 Million
Q3 2019 Oct 29, 2019	BUY	$17.99 - $26.0 $1.66 Million - $2.4 Million	92,206 Added 7.29%	1,356,302 $24.7 Million
Q2 2019 Jul 29, 2019	BUY	$9.78 - $24.52 $7.83 Million - $19.6 Million	801,026 Added 172.98%	1,264,096 $31 Million
Q1 2019 Apr 30, 2019	BUY	$8.41 - $11.26 $3.89 Million - $5.21 Million	463,070 New	463,070 $4.4 Million

Others Institutions Holding IOVA

# of Institutions

318

Shares Held

244M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $963M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account